This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The Deal: Overseas Stocks Trade Mixed; Nikkei Rises 1.3%

LONDON (The Deal) -- Overseas stocks were mixed Monday as the devastating typhoon Haiyan took its toll on some Asian indices and investors contemplated an imminent paring of the Federal Reserve's monthly bond buying program following last week's strong U.S. labor market figures.

In Manila, the PSEi lost 1.4% after the typhoon wrought devastation on the Philippines and killed an estimated 10,000 people. The larger Asian indices closed up, however, with the Hang Seng in Hong Kong gaining 1.4% to 23,069.85 and the Nikkei 225 in Tokyo rising 1.3% to close at 14,269.84. Mainland Chinese indices also closed higher as top Communist leaders near the end of a four-day economic gathering. State-backed China Daily said that China is preparing to open up its powerful state-owned enterprises to foreign investors, which may be able to buy stakes of between 10% and 15% in those companies.

In Milan, the FTSE MIB index lost ground after September and third-quarter industrial output figures painted a weak picture of the Italian economy.
In Frankfurt, the DAX was little changed at 9,081.19 and in Paris the CAC 40 was also broadly stable as the country enjoyed its Armistice Day public holiday.

In the U.K., the FTSE edged up 0.07% to 6,713.00.

Insurer RSA Group was down almost 11% by mid-morning after it said it had suspended top executives at its Irish division and that unspecified "issues" at the unit would weigh on full-year profit to the tune of 70 million pounds ($112.1 million). The late Friday announcement followed a warning just three days earlier that weather-related claims, including those arising from the St. Jude's Day storm in the U.K., would hamper its full-year return on equity.

Irish drugs maker Shire gained 3.5% in London as it announced the $4.2 billion purchase of Nasdaq-listed ViroPharma (VPHM), whose main product treats hereditary angioedema, a disease that causes skin swelling. Shire said the purchase would boost its own earnings immediately.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
VPHM $49.96 -0.02%
AAPL $93.14 -1.10%
FB $117.56 -0.42%
GOOG $704.24 1.20%
TSLA $210.83 -5.30%


Chart of I:DJI
DOW 17,638.52 -22.19 -0.13%
S&P 500 2,042.95 -7.68 -0.37%
NASDAQ 4,695.9680 -21.1260 -0.45%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs